Skip to Content

WAT SON 406 (Lisinopril 5 mg)

Pill with imprint WAT SON 406 is White, Elliptical / Oval and has been identified as Lisinopril 5 mg. It is supplied by Watson Pharmaceuticals.

Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WAT SON 406

Lisinopril 5 mg WAT SON 406 Front
Lisinopril 5 mg WAT SON 406 Back
Lisinopril 5 mg WAT SON 406
Lisinopril 5 mg WAT SON 406

Lisinopril

Imprint
WAT SON 406
Strength
5 mg
Color
White
Size
10.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-0406
Inactive Ingredients
silicon dioxide, calcium phosphate dihydrate dibasic, magnesium stearate, mannitol, corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.